|Over a week ago|
LifeSpeak initiated with a Buy at Roth Capital » 06:5311/1511/15/21
Roth Capital analyst Jeff…
Roth Capital analyst Jeff Martin initiated coverage of LifeSpeak with a Buy rating and C$12 price target. The shares are down 30% from the July initial public offering price, representing an attractive risk/reward opportunity for a "high margin, high growth business" that targets mental health and wellbeing education, with significant pipeline conversion potential, Martin tells investors in a research note.
LifeSpeak initiated with a Buy at Stifel » 07:5411/0911/09/21
Stifel analyst Justin…
Stifel analyst Justin Keywood initiated coverage of LifeSpeak with a Buy rating and C$11.50 price target. The company provides an asset-light mental health and well-being platform to corporations through curated proprietary video content delivered as a SaaS offering with "high recurring revenue," said Keywood. LifeSpeak customers and HR experts that he spoke with mentioned the platform as "unique without a comparable competitive alternative" and described "exceptional customer service" as well, said Keywood.
|Over a month ago|
LifeSpeak initiated with a Buy at Desjardins » 16:1710/2610/26/21
Desjardins initiated coverage of LifeSpeak with a Buy rating and C$13 price target.
|Over a quarter ago|
LifeSpeak initiated with a Buy at Canaccord » 07:4407/2607/26/21
Canaccord analyst Doug…
Canaccord analyst Doug Taylor initiated coverage of LifeSpeak with a Buy rating and C$13 price target. The company has developed an expansive, curated library of videos and related materials delivered on a subscription basis, Taylor tells investors in a research note. The analyst says that as LifeSpeak builds a track record of pipeline conversion in the coming quarters, there is valuation upside from these levels.